Collegium Pharmaceutical (COLL) has been drawing investor attention after recent share moves, with the stock up about 31% over the past 3 months, even as the past month shows a 7% decline. See our ...

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to ...

Book cover courtesy of Susan Coll. Susan Coll was already an established novelist when she started working at Politics and Prose in 2011, and she promised the store’s owners that she wouldn’t write ...

As of Friday, January 09, Collegium Pharmaceutical, Inc.’s COLL share price has dipped by 6.84%, which has investors questioning if this is right time to buy.

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations for ...

ANNAPOLIS, MD — The presidential race gets the most attention, but Maryland has several Congressional contests as well. The state's eight seats in the U.S. House of Representatives are also up for ...

It was 5am when a phone rang in a house near Palma de Mallorca, Spain. The time did not bode well, but Cata Coll’s father picked up. “Dad, today I’m starting,” said his daughter, calling from almost ...

While the proven Zacks Rank places an emphasis on earnings estimates and estimate revisions to find strong stocks, we also know that investors tend to develop their own individual strategies. With ...